SARA CHASTEEN: Open Payments
NPI 1124490370 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 161 payments from 16 companies in 2025. Trend: 2023 $1,774 · 2024 $2,357 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $435 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $326 |
| Janssen Biotech, Inc. | 16 | $281 |
| Regeneron Healthcare Solutions, Inc. | 12 | $256 |
| Madrigal Pharmaceuticals | 17 | $229 |
| Phathom Pharmaceuticals, Inc. | 17 | $212 |
| GENZYME CORPORATION | 12 | $175 |
| Ardelyx, Inc. | 12 | $157 |
| Lilly USA, LLC | 7 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
Products named: DUPIXENT, XIFAXAN, TREMFYA, REZDIFFRA, VOQUEZNA, IBSRELA, OMVOH, LINZESS.
Industry payments across KY — which companies pay providers there.
